Dishman Carbogen Amcis Appoints Sandeep Jaiswal as Vice President of International Marketing
Dishman Carbogen Amcis Limited has appointed Mr. Sandeep Jaiswal as its Vice President (International Marketing), effective April 20, 2026. The appointment was made following internal procedures approved by the company's Nomination and Remuneration Committee.The strategic addition to the senior management team strengthens the company's international marketing capabilities.
According to the details provided regarding the change in senior management personnel, the key information surrounding the role change is as follows:
| Particular | Detail |
|---|---|
| Name | Mr. Sandeep Jaiswal |
| Reason for Change | Appointment as Vice President (International Marketing) |
| Date of Appointment | 20th April, 2026 |
| Term of Appointment | Subject to the terms and conditions outlined in the Letter of Appointment |
The article details the professional background of Mr. Jaiswal, noting his age is approximately 51 years. He brings 27 years of rich experience across various segments, including Business Development, Marketing & Sales of Active Pharmaceuticals Ingredients (APIs), Speciality Chemicals, Intermediaries, and Food Activities.
Mr. Jaiswal holds a PGDM in Marketing & International Business and a B.Sc. in Chemistry & Botany. Prior to joining Dishman Carbogen Amcis Limited, he was serving as General Manager - Marketing at Apotex Pharmachem India PVT. LTD., based in Bangalore.
DCAL Stock Price Movement
Today, Dishman Carbogen Amcis Limited shares edged higher to close at ₹168.74, gaining 0.04% in post-market trading. The stock saw a substantial volume of 471,686 shares traded throughout the session.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.